Seeing Is Believing
GLMD is currently covered by 1 analysts with an average price target of $716.3. This is a potential upside of $713.55 (25947.27%) from yesterday's end of day stock price of $2.75.
Galmed Pharmaceuticals Ltd's activity chart (see below) currently has 11 price targets and 25 ratings on display. The stock rating distribution of GLMD is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 38.89% with an average time for these price targets to be met of 367.78 days.
Highest price target for GLMD is $15, Lowest price target is $15, average price target is $716.3.
Most recent stock forecast was given by JASON MCCARTHY from MAXIM GROUP on 24-Jul-2023. First documented stock forecast 08-Jul-2015.
Currently out of the existing stock ratings of GLMD, 1 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$48
$45.07 (1538.23%)
1 years 3 months 29 days ago
(24-Jul-2023)
1/2 (50%)
$33.48 (230.58%)
89
Buy
2 years 3 months 14 days ago
(08-Aug-2022)
0/2 (0%)
$4172.4 (398.28%)
Buy
$13
2 years 3 months 18 days ago
(04-Aug-2022)
2/2 (100%)
$-34.55 (-72.66%)
291
Hold
2 years 6 months 4 days ago
(18-May-2022)
1/2 (50%)
$-541.2 (-59.07%)
580
Hold
2 years 6 months 4 days ago
(18-May-2022)
1/2 (50%)
$1481.4 (84.24%)
2101
What is GLMD (Galmed Pharmaceuticals Ltd) average time for price targets to be met?
Which analyst has the current highest performing score on GLMD (Galmed Pharmaceuticals Ltd) with a proven track record?
Which analyst has the current lower performing score on GLMD (Galmed Pharmaceuticals Ltd) with a proven track record?
Which analyst has the most public recommendations on GLMD (Galmed Pharmaceuticals Ltd)?
Which analyst is the currently most bullish on GLMD (Galmed Pharmaceuticals Ltd)?
Which analyst is the currently most reserved on GLMD (Galmed Pharmaceuticals Ltd)?